Overview

Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.

NDC labeler codes
0186, 0310
Strengths
Budesonide 160 ug/1; Formoterol fumarate 4.5 ug/1; Budesonide 80 ug/1; Acalabrutinib 100 mg/1; Metformin hydrochloride 1000 mg/1; Dapagliflozin propanediol 5 mg/1; Dapagliflozin propanediol 10 mg/1; Eplontersen 45 mg/.8mL; Formoterol 4.8 ug/1; Glycopyrrolate 9 ug/1; Benralizumab 30 mg/mL; Olaparib 150 mg/1; Olaparib 100 mg/1; Osimertinib 40 mg/1; Osimertinib 80 mg/1; Pramlintide acetate 1000 ug/mL; Exenatide 250 ug/mL; Metformin hydrochloride 500 mg/1; Quetiapine fumarate 200 mg/1; Quetiapine fumarate 300 mg/1
Dosage forms
Tablet, Film coated, Injection, Solution, Injection, Tablet, Film coated, Extended release, Granule, Delayed release, Aerosol, Metered, Aerosol, Tablet, Tablet, Extended release, Suspension, Granule, Capsule, Powder, For suspension, Capsule, Delayed release, Injection, Powder, Lyophilized, For solution, Capsule, Gelatin coated, Tablet, Coated
Routes
Oral, Respiratory (Inhalation), Subcutaneous, Intravenous, Intramuscular
Drug classes (FDA established)
Kinase Inhibitor, Corticosteroid, Atypical Antipsychotic, beta2-Adrenergic Agonist, Sodium-Glucose Cotransporter 2 Inhibitor, Proton Pump Inhibitor, Biguanide, HMG-CoA Reductase Inhibitor, Poly(ADP-Ribose) Polymerase Inhibitor, Anticholinergic, Cholinergic Muscarinic Antagonist, Interleukin-5 Receptor alpha-directed Cytolytic Antibody, Antisense Oligonucleotide, Transthyretin-directed RNA Interaction, Type I Interferon Receptor Antagonist, CTLA-4-directed Blocking Antibody, Programmed Death Ligand-1 Blocker, P2Y12 Platelet Inhibitor, Phosphodiesterase 4 Inhibitor, Amylin Analog, GLP-1 Receptor Agonist, Estrogen Receptor Antagonist
Package NDCs
127

NDC codes

Newest listings first. Each row links to the product’s NDC page.

AstraZeneca Pharmaceuticals LP NDC Codes: finished products
ProductStrengthForm · routeProduct NDCPackage NDCs (11-digit)HCPCS
EtcamahcamizestrantCamizestrant 75 mg/1Tablet, Film coatedOral0310-007500310-0075-0100310-0075-95—
BaxfendybaxdrostatBaxdrostat 1 mg/1Tablet, Film coatedOral0310-600100310-6001-3000310-6001-95—
BaxfendybaxdrostatBaxdrostat 2 mg/1Tablet, Film coatedOral0310-600200310-6002-3000310-6002-95—
WainuaeplontersenEplontersen 45 mg/.8mLInjection, SolutionSubcutaneous0310-942000310-9420-01—
Breztribudesonide, glycopyrrolate, and formoterol fumarateBudesonide 160 ug/1 + 2 more ingredientsAerosol, MeteredRespiratory (Inhalation)0310-661600310-6616-0100310-6616-3900310-6616-95—
Saphneloanifrolumab-fniaAnifrolumab 120 mg/.8mLInjection, SolutionSubcutaneous0310-308000310-3080-0100310-3080-0200310-3080-95—
KoselugoselumetinibSelumetinib 5 mg/1GranuleOral0310-063500310-0635-60—
KoselugoselumetinibSelumetinib 7.5 mg/1GranuleOral0310-064000310-0640-60—
FasenrabenralizumabBenralizumab 10 mg/.5mLInjection, SolutionSubcutaneous0310-174500310-1745-0100310-1745-95—
WainuaeplontersenEplontersen 45 mg/.8mLInjection, SolutionSubcutaneous0310-940000310-9400-01—
TruqapcapivasertibCapivasertib 160 mg/1Tablet, Film coatedOral0310-950000310-9500-0100310-9500-02—
TruqapcapivasertibCapivasertib 200 mg/1Tablet, Film coatedOral0310-950100310-9501-0100310-9501-0200310-9501-04+1 more—
Airsupraalbuterol sulfate and budesonideAlbuterol sulfate 90 ug/1; Budesonide 80 ug/1Aerosol, MeteredRespiratory (Inhalation)0310-908000310-9080-1200310-9080-28—
ImjudotremelimumabTremelimumab 300 mg/15mLInjection, SolutionIntravenous0310-453500310-4535-30—
ImjudotremelimumabTremelimumab 25 mg/1.25mLInjection, SolutionIntravenous0310-450500310-4505-25—
CalquenceacalabrutinibAcalabrutinib 100 mg/1Tablet, Film coatedOral0310-451300310-4513-60—
CalquenceacalabrutinibAcalabrutinib 100 mg/1Tablet, Film coatedOral0310-351200310-3512-6000310-3512-95—
Andexxaandexanet alfaAndexanet alfa 200 mg/20mLInjection, Powder, Lyophilized, For solutionIntravenous0310-320000310-3200-0400310-3200-05—
CrestorrosuvastatinRosuvastatin calcium 5 mg/1Tablet, Film coatedOral0310-756000310-7560-90—
CrestorrosuvastatinRosuvastatin calcium 10 mg/1Tablet, Film coatedOral0310-757000310-7570-90—
CrestorrosuvastatinRosuvastatin calcium 20 mg/1Tablet, Film coatedOral0310-758000310-7580-90—
CrestorrosuvastatinRosuvastatin calcium 40 mg/1Tablet, Film coatedOral0310-759000310-7590-30—
Saphneloanifrolumab-fniaAnifrolumab 300 mg/2mLInjection, SolutionIntravenous0310-304000310-3040-00—
Breztribudesonide, glycopyrrolate, and formoterol fumarateBudesonide 160 ug/1 + 2 more ingredientsAerosol, MeteredRespiratory (Inhalation)0310-461600310-4616-1200310-4616-2800310-4616-39—
KoselugoselumetinibSelumetinib 10 mg/1CapsuleOral0310-061000310-0610-2800310-0610-60—
KoselugoselumetinibSelumetinib 25 mg/1CapsuleOral0310-062500310-0625-2800310-0625-60—
Budesonide and Formoterol Fumarate DihydrateBudesonide 160 ug/1; Formoterol fumarate 4.5 ug/1AerosolRespiratory (Inhalation)0310-737000310-7370-20—
Budesonide and Formoterol Fumarate DihydrateBudesonide 80 ug/1; Formoterol fumarate 4.5 ug/1AerosolRespiratory (Inhalation)0310-737200310-7372-20—
FasenrabenralizumabBenralizumab 30 mg/mLInjection, SolutionSubcutaneous0310-183000310-1830-3000310-1830-85—
Lokelmasodium zirconium cyclosilicateSodium zirconium cyclosilicate 5 g/5gPowder, For suspensionOral0310-110500310-1105-3000310-1105-39—
Lokelmasodium zirconium cyclosilicateSodium zirconium cyclosilicate 10 g/10gPowder, For suspensionOral0310-111000310-1110-3000310-1110-3900310-1110-93—
FasenrabenralizumabBenralizumab 30 mg/mLInjection, SolutionSubcutaneous0310-173000310-1730-3000310-1730-85—
CalquenceacalabrutinibAcalabrutinib 100 mg/1Capsule, Gelatin coatedOral0310-0512——
LynparzaolaparibOlaparib 150 mg/1Tablet, Film coatedOral0310-057800310-0578-1200310-0578-60—
LynparzaolaparibOlaparib 100 mg/1Tablet, Film coatedOral0310-066800310-0668-1200310-0668-6000310-0668-95—
LynparzaolaparibOlaparib 150 mg/1Tablet, Film coatedOral0310-067900310-0679-1200310-0679-6000310-0679-95—
LynparzaolaparibOlaparib 100 mg/1Tablet, Film coatedOral0310-056900310-0569-1200310-0569-60—
ImfinzidurvalumabDurvalumab 500 mg/10mLInjection, SolutionIntravenous0310-461100310-4611-50J9173
ImfinzidurvalumabDurvalumab 120 mg/2.4mLInjection, SolutionIntravenous0310-450000310-4500-12J9173
Bevespi Aerosphereglycopyrrolate and formoterol fumarateGlycopyrrolate 9 ug/1; Formoterol fumarate 4.8 ug/1Aerosol, MeteredRespiratory (Inhalation)0310-460000310-4600-12—
TagrissoosimertinibOsimertinib 40 mg/1Tablet, Film coatedOral0310-124800310-1248-30—
TagrissoosimertinibOsimertinib 80 mg/1Tablet, Film coatedOral0310-125100310-1251-30—
TagrissoosimertinibOsimertinib 40 mg/1Tablet, Film coatedOral0310-134900310-1349-30—
TagrissoosimertinibOsimertinib 80 mg/1Tablet, Film coatedOral0310-135000310-1350-3000310-1350-99—
BrilintaticagrelorTicagrelor 60 mg/1TabletOral0186-077600186-0776-60—
IressagefitinibGefitinib 250 mg/1Tablet, CoatedOral0310-048200310-0482-30—
DaliresproflumilastRoflumilast 250 ug/1TabletOral0310-008800310-0088-2800310-0088-39—
DaliresproflumilastRoflumilast 500 ug/1TabletOral0310-009500310-0095-3000310-0095-90—
SymlinPenpramlintide acetatePramlintide acetate 1000 ug/mLInjectionSubcutaneous0310-661500310-6615-02—
SymlinPenpramlintide acetatePramlintide acetate 1000 ug/mLInjectionSubcutaneous0310-662700310-6627-02—

AstraZeneca Pharmaceuticals LP: common questions

What is AstraZeneca Pharmaceuticals LP's NDC labeler code?
0186, 0310. The labeler code is the first segment of each NDC. About labeler codes.
Is there a J-code for AstraZeneca Pharmaceuticals LP?
Med-Code's HCPCS directory matches J9173 to these products. NDC vs J-code.
Which NDC goes on a claim?
The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in
AstraZeneca Pharmaceuticals LP NDC Codes | Med-Code